Alterations in striatal neurotrophic activity induced by dopaminergic drugs
- 1 September 1993
- journal article
- review article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 46 (1) , 195-204
- https://doi.org/10.1016/0091-3057(93)90340-y
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Membrane Depolarization Induces p140 trk and NGF Responsiveness, but Not p75 LNGFR , in MAH CellsScience, 1992
- The potential use of a dopamine neuron antibody and a striatal‐derived neurotrophic factor as diagnostic markers in Parkinson's diseaseNeurology, 1991
- Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigmEuropean Journal of Pharmacology, 1990
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivityPharmacology Biochemistry and Behavior, 1990
- Chapter 78 Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factorPublished by Elsevier ,1990
- Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferationLife Sciences, 1988
- Adrenal Medulla Grafts Enhance Recovery of Striatal Dopaminergic FibersScience, 1987
- The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivityEuropean Journal of Pharmacology, 1986
- Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugsJournal of Pharmacy and Pharmacology, 1972